Bos, V., Crouwel, F., Waaijenberg, P., Bouma, G., Duijvestein, M., Buiter, H., Brand, H., Hamer, H., & de Boer, N. (2022). Salivary Calprotectin Is not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases, 31(3), 283-289. https://doi.org/10.15403/jgld-4215